Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov:51 Suppl 7:89-117.
doi: 10.1111/imj.15589.

Consensus guidelines for the diagnosis and management of invasive candidiasis in haematology, oncology and intensive care settings, 2021

Caitlin Keighley  1   2   3 , Louise Cooley  4   5 , Arthur J Morris  6 , David Ritchie  7 , Julia E Clark  8   9 , Peter Boan  10   11 , Leon J Worth  12   13 ; Australasian Antifungal Guidelines Steering Committee
Collaborators, Affiliations

Consensus guidelines for the diagnosis and management of invasive candidiasis in haematology, oncology and intensive care settings, 2021

Caitlin Keighley et al. Intern Med J. 2021 Nov.

Abstract

Patients with haematological malignancies, haemopoietic stem cell transplant recipients and patients requiring admission to intensive care settings are at high risk for invasive candidiasis (IC). Over the past decade, there has been increased reporting of non-albicans species and fluconazole resistance in Australia. These guidelines provide updated evidence-based recommendations for the diagnosis and management of IC in adult and paediatric haematology, oncology and intensive care settings. Optimal pharmacological and non-pharmacological management are discussed. Recent studies strengthen the recommendation for an echinocandin agent as first-line therapy for high-risk patients with IC. Mortality benefit has also been demonstrated for non-pharmacological management, including removal of central venous catheters, infectious diseases consultation and use of care bundles. Healthcare facilities managing immunocompromised patient populations should therefore adopt implementation strategies for these multimodal interventions.

Keywords: antifungal therapy; candidaemia; consensus guidelines; diagnosis; invasive candidiasis; prevention.

PubMed Disclaimer

References

    1. Chen SC, Sorrell TC, Chang CC, Paige EK, Bryant PA, Slavin MA. Consensus guidelines for the treatment of yeast infections in the haematology, oncology and intensive care setting, 2014. Intern Med J 2014; 44: 1315-32.
    1. Borman AM, Johnson EM. Name changes for fungi of medical importance, 2018 to 2019. J Clin Microbiol 2021; 59: e01811-20.
    1. Chapman B, Slavin M, Marriott D, Halliday C, Kidd S, Arthur I et al. Changing epidemiology of candidaemia in Australia. J Antimicrob Chemother 2017; 72: 1103-8.
    1. Kofteridis DP, Valachis A, Dimopoulou D, Andrianaki AM, Christidou A, Maraki S et al. Factors influencing non-albicans candidemia: a case-case-control study. Mycopathologia 2017; 182: 665-72.
    1. Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med 2014; 370: 1198-208.

LinkOut - more resources